DOP Session 1

DOP01-09

  • 17:30-18:30 Digital Oral Presentation Session 1: Advances in IBD pathophysiology
    Room: C1-M1, Hall C, Bella Center
    Chairs: Javier Gisbert, Madrid, Spain
    Maximilian Waldner, Erlangen, Germany
      17:30-17:36 DOP01: Extracellular nicotinamide phosphoribosyltransferase (eNAMPT): Possible new target and biomarker in Inflammatory Bowel Diseases
    G. Colombo
    1, C. Travelli1, C. Porta1, G. Stocco2, F. Malavasi3, A. A. Genazzani1
    1
    Università del Piemonte Orientale, Department of Pharmaceutical Sciences UNIUPO, Novara, Italy, 2Università degli studi di Trieste, Departement of Chemical and Pharmaceutical Sciences, Trieste, Italy, 3Università degli Studi di Torino, Department of Medical Science, Torino, Italy
      17:36-17:42 DOP02: Supplementation with butyrate producing bacteria reduces tumor load in a mouse model of Colitis associated cancer
    A. Montalban Arques
    1, I. Olivares Rivas1, K. Atrott1, C. Gottier1, S. Lang1, G. Leventhal2, T. DeWouters3, M. Scharl1, M. Spalinger1
    1
    University Hospital Zurich, Gastroenterology and Hepatology, Zurich, Switzerland, 2Massachusetts Institute of Technology, Department of Civil and Environmental Engineering, Cambridge, United States, 3Pharmabiome, Zurich, Switzerland
      17:42-17:48 DOP03: The correlation of regulatory miRNAs with cytokine serum levels and cytokine genes’ polymorphisms
    A. Surowiecka-Pastewka
    1, 2, M. Zagozda2, E. Zakościelna2, M. Durlik1, 2
    1
    CSK Mswia, Department of Gastroenterological Surgery and Transplantation, Warsaw, Poland, 2Mossakowski Medical Research Centre of the Polish Academy of Sciences, Department of Surgical Research and Transplantology, Warsaw, Poland
      17:48-17:54 DOP04: The ability of epithelial regeneration is reduced in the Crohn’s Disease patient-derived organoids, especially in TNF-α enriched condition
    J. H. Song, S. N. Hong, G. Seong, T. J. Kim, E. R. Kim, D. K. Chang, Y.-H. Kim, C. Lee, C. Lee
    Samsung Medical Center, Seoul, South Korea
      17:54-18:00 DOP05: Adipose-derived stem cells from Crohn’s Disease patients show antigen presenting cell-like properties
    C. Serena
    1, M. Terrón-Puig1, M. Ejarque1, F. Algaba-Chueca1, E. Maymó-Masip1, M. Millan2, M. Menacho3, E. Espin4, M. Martí4, S. Fernández-Veledo1, J. Vendrell1
    1Health Institute Pere Virgili, Hospital Joan XXIII, Tarragona, Spain, 2Hospital Joan XXIII, Colorectal Surgery Unit, Tarragona, Spain, 3Hospital Joan XXIII, Digestive Unit, Tarragona, Spain, 4Hospital Vall Hebrón, Colorectal Surgery Unit, General Surgery Service, Barcelona, Spain
       18:00-18:06 DOP06: Dynamic shifts in the balance of gut homing Treg and Th17 cells play a critical role in Ulcerative Colitis and may predict response to vedolizumab therapy
    S. Hermangild Kottoor
    1, Z. Kassam1, P. Pavlidis1, 2, E. Alberts1, H. Ibraheim1, 2, L. Constable1, J. Digby-Bell1, D. Warren2, S. Odukwe2, M. Samaan2, P. Irving2, J. Sanderson2, N. Powell1, 2
    1
    King's College London, School of Immunology and Microbial sciences, London, United Kingdom, 2Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom
       18:06-18:12 DOP07: IMP761, a novel anti-LAG-3 agonist antibody for the treatment of auto-immune diseases
    M. Angin, C. Brignone, F. Triebel
    Immutep, Orsay, France
      18:12-18:18 DOP08: The regulatory landscape of intestinal cells – investigating the transcriptional effect of autophagy impairment observed in Crohn’s Disease using organoid and network biology approaches
    A. Treveil
    1, 2, P. Sudhakar1, 3, Z. Matthews4, T. Wrzesinkski1, E. Jones1, 2, P. Powell4, T. Wileman2, 4, I. Hautefort1, L. Hall2, F. Di Palma1, W. Haerty1, T. Korcsmaros1, 2
    1
    Earlham Institute, Norwich, United Kingdom, 2Quadram Institute, Norwich, United Kingdom, 3Catholic University of Leuven, Translational Research in Gastrointestinal Disorders, Leuven, Belgium, 4University of East Anglia, Norwich Medical School, Norwich, United Kingdom
     
      18:18-18:24 DOP09: Interleukin-20 subfamily cytokines in controlling intestinal inflammation and epithelial barrier integrity
    M. Moniruzzaman
    1, 2, R. Wang2, K. Wong2, H. Tong2, M. McGuckin3, S. Hasnain1, 2
    1
    Faculty of Medicine, The University of Queensland, Brisbane, Australia, 2Immunopathology Group, Mater Research Institute - The University of Queensland, Translational Research Institute, Brisbane, Australia, 3Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia

Digital Oral Presentations
(as of January 2019)

  • DOP Session 1 Advances in IBD pathophysiology
    DOP01-09
    Room: C1 M1
    Chairs: Javier Gisbert, Madrid, Spain
    Maximilian Waldner, Erlangen, Germany
    DOP Session 2 Mechanisms of intestinal inflammation
    DOP10-18
    Room: C1 M0
    Chairs: Loris Riccardo Lopetuso, Rome, Italy
    Britta Siegmund, Berlin, Germany
    DOP Session 3 Translational science in IBD
    DOP19-27
    Room: C1 M2
    Chairs: Peter Bossuyt, Bonheiden, Belgium
    Axel Dignass, Frankfurt, Germany
    DOP Session 4 Practicalities of IBD patient care
    DOP28-36
    Room: C1 M3
    Chairs: Uri Kopylov, Tel Aviv, Israel
    Fernando Magro, Porto, Portugal
    DOP Session 5 Old and new treatment
    DOP37-45
    Room: C1 M4-5
    Chairs: Paolo Gionchetti, Bologna, Italy
    Anne Strik, Amsterdam, The Netherlands
  • DOP Session 6 Novel treatments
    DOP46-54
    Room C1 M4-5
    Chairs: Marc Ferrante, Leuven, Belgium
    Gionata Fiorino, Rome, Italy
    DOP Session 7 Recent advances of biologic therapies
    DOP55-63
    Room: C1 M3
    Chairs: Filip Baert, Roeselare, Belgium
    Shomron Ben-Horin, Ramat Gan, Israel
    DOP Session 8 Intestinal healing
    DOP64-72
    Room: C1 M2
    Chairs: Raja Atreya, Erlangen, Germany
    Marietta Iacucci, Birmingham, United Kingdom
    DOP Session 9 Surgery and IBD
    DOP73-81
    Room: C1 M1
    Chairs: Paulo Kotze, Curitiba, Brazil
    Andre D'Hoore, Leuven, Belgium
    DOP Session 10 Clinical epidemiology
    DOP82-90
    Room: C1 M0
    Chairs: Stefanos Bonovas, Milan, Italy
    Johan Burisch, Copenhagen, Denmark